Hint mode is switched on Switch off
Cbonds API
Integrate prices, fundamentals and corporate actions into your workflow

Get Global Stock Data via API

  • Prices & history
  • Fundamentals
  • Dividends & corporate actions

Monte Rosa Therapeutics, ordinary share
GLUE, US61225M1027

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access
Add a stock to WL
Choose all Reset all
Save Close
Monte Rosa Therapeutics, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Latest quotes

Included in the Free Plan
  • 100,000+ Stocks
  • 17,000+ ETFs
  • 150,000+ Mutual Funds

Start exploring global markets in less than 1 minute

  • Global Macro & Commodity Data
  • Research Hub & Basic Market News
  • AI Bond Screener
Free Plan
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Monte Rosa Therapeutics, Inc. operates as a biotechnology company. The Company focuses on developing molecular glues to degrade disease-causing proteins. Monte Rosa Therapeutics serves customers in the United States and Switzerland.
  • Issuer
  • Full borrower / issuer name
    Monte Rosa Therapeutics, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    GLUE
  • Placement
    24.06.2021
  • Lock up period
    180
  • Number of papers
    11,700,000
  • Volume of raised funds
    222.3 mln USD
  • Raised funds in USD
    -
  • Placement share
    26.3%
  • Final placement price
    19 USD
  • Price change since placement date
    -100%
  • By capitalization
    845.31 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    GLUE
  • Placement
    09.01.2026
  • Lock up period
    180
  • Number of papers
    11,125,000
  • Volume of raised funds
    267 mln USD
  • Raised funds in USD
    -
  • Placement share
    15.26%
  • Final placement price
    24 USD
  • Price change since placement date
    -100%
  • By capitalization
    1,749.97 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    GLUE
  • Placement
    16.05.2024
  • Lock up period
    180
  • Number of papers
    10,638,476
  • Volume of raised funds
    50 mln USD
  • Raised funds in USD
    -
  • Placement share
    17.49%
  • Final placement price
    4.7 USD
  • Price change since placement date
    -100%
  • By capitalization
    285.94 mln USD
Other placements of the issuer Hide

Indicators

IFRS/US GAAP reports

  • 2026

  • 2025

  • 2024

  • 2023

  • 2022

  • 2021

    • News

    All organization news

    Holders

    Related Stock indices

    • NASDAQ Composite
      27,068.72
      Value
      25/09/2026
      Date

    Industry Leaders

    Registration is required to get access.